EDITOR-IN-CHIEF Richard M. Kostrzewa, Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State Univ., Johnson City TN, USA ASSOCIATE EDITORS Mario Herrera-Marschitz, Program of Molecular and Clinical Pharmacology, University of Chile, Santiago, Chile Xin-Fu Zhou, School of Pharmacy and Medical Sciences, Faculty of Health Sciences, University of South Australia, Adelaide, Australia EDITORIAL BOARD Lucyna Antkiewicz-Michaluk, Department of Neurochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland Marta C. Antonelli, Instituto de Biología Celular y Neurociencias "Prof. E. De Robertis", CONICET-UBA, Universidad de Buenos Aires, Argentina Trevor Archer, Department of Psychology, Universities of Göteborg and Kalmar, Sweden Masato Asanuma, Department of Brain Sciences, Okayama University, Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Japan Rommy von Bernhardi, Departamento de Neurología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile Rryszard Brus, Department of Nursing, High School of Strategic Planning, Dabrowa Gornicza, Poland Vladimir L. Buchman, School of Biosciences, Cardiff University, Cardiff, UK Anna R. Carta, Department of Biomedical Sciences, University of Cagliari, Italy Jean Lud Cadet, Molecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, NIH, Baltimore, MD, USA Sandra Ceccatelli, Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden Michael A. Collins, Department of Molecular Pharmacology & Therapeutics, Loyola University, Chicago, Stritch School of Medicine, Maywood, IL, USA Cynthia A. Crawford, Department of Psychology, California State University, San Bernardino, CA, USA Wojciech Danysz, Merz Pharmaceuticals GmbH, Frankfurt/Main, Germany Elaine Del-Bel, Department of Morphology Physiology & Basic Pathology, Dental School of Ribeirão Preto, University of São Paulo, Brazil Malgorzata Filip, Laboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland Fabio Fumagalli, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy Raul Gainetdinov, Department of Neuroscience & Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy; Skolkovo Institute of Science & Technology, Moscow Region, Russia; Institute of Translational Biomedicine, St. Petersburg State University, Russia Krystyna Gołembiowska, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland Gilles Guillemin, Neuropharmacology Group, MND & Neurodegenerative Diseases Research Center, Macquarie University, Sydney, Australia G. Jean Harry, Neurotoxicology Group, National Toxicology Program Laboratory, NIEHS/NIH, Research Triangle Park, NC, USA Maria-Trinidad Herrero Ezquerro, Clinical & experimental Neuroscience, Department of Human Anatomy & Psychobiology, University of Murcia, Spain Danuta Jantas, Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland Kristen A. Keefe, Interdepartmental Program in Neuroscience, University of Utah, Salt Lake City, UT, USA Władysław Lasoń, Department of Experimental Neuroendocrinology, Director – Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland J. William Langston, Parkinson's Institute and Clinical Center, Sunnyvale, CA, USA Giovanni Laviola, Department of Cell Biology and Neuroscience, Section of Behavioural Neuroscience, Istituto Superiore di Sanità Roma, Italy Italo Mocchetti, Department of Neuroscience, Laboratory of Preclinical Neurobiology, Georgetown University Medical Center, Washington, DC, USA Rosario Moratalla, Instituto Cajal, CSIC and 5CIBERNED, Instituto de Salud Carlos III, Madrid, Spain Micaela Morelli, Deparment of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari; Institute of Neuroscience, Cagliari, Italy Hiroku Nawa, Department of Molecular Biology, Brain Research Institute, Niigata University, Niigata, Japan Tomas Palomo, Psychiatry Deparment, Laboratory of Neurosciences, Instituto de Investigación Sanitaria del Hospital Universitario, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Spain Rui D. Prediger, Departamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil Rita Raisman-Vozari, INSERM, Thérapeutique Expérimentale de la Neurodégénérescence, Hôpital de la Salpetrière -ICM , Paris, France Dora Reglodi, Department of Anatomy, MTA-PTE PACAP Lendulet Research Group, Medical School, University of Pecs, Pecs, Hungary Peter Riederer, Center of Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Germany Richard Salvi, Center for Hearing and Deafness, State University of New York at Buffalo, Buffalo, NY, USA Abel Santamaria, Head – Lab de Aminoácidos Excitadores, Inst Nacional de Nueorlogía y Neurocirurgía Insurgentes, Mexico City, Mexico Arne Schousboe, Department of Drug Design and Pharmacology, Faculty of Health and Medicine, University of Copenhagen, Denmark Juan Segura-Aguilar, Department of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile Nadia Stefanova, Division of Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria Harry W.M. Steinbusch, Department of Cellular Neuroscience, Faculty of Health, Medicine & Life Sciences, Maastricht University, Netherlands Yousef Tizabi, Department of Pharmacology, Howard University College of Medicine, Washington, DC, USA Moacir Wajner, Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil Yanjiang Wang, Department of Neurology & Centre for Clinical Neuroscience, Third Military Medical University, Chongqing, China Orly Weinreb, Eve Topf Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Xingshun Xu, Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China Luigi Zecca, Institute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy
|